C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes

TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B. Helmsley Charitable Trust, a new research grant aimed at developing a novel treatment for type 1 diabetes (T1D). This award is made through TRxA’s Bridging Research and Innovation in Drug Development Grants (BRIDGe) program, which is designed to support academic researchers in traversing the drug development valley of death and advancing new cutting-edge therapeutics from the lab to patients. Continue reading

Applications are open for Venture Madness 2025

The application window for #VM25 is NOW open and closes on December 18, 2024 (3pm AZ time). The Venture Madness Conference is Arizona’s longest-running capital conference and early-stage pitch event that connects serious investors with the best and brightest ventures in Arizona! Since the inception of this conference, more than $1B in funding has been raised by presenting companies.Continue reading